The endoscope reprocessing market is projected to reach USD 3.2 billion by 2026, at a CAGR of 9.0% from 2021 to 2026. The increasing preference for endoscopic procedures, high risk of endoscope-associated infections, growing geriatric population and the subsequent increase of endoscopic procedures, and increasing emphasis on improving reprocessing guidelines by healthcare facilities in the market during the forecast period.
Driver: High risk of endoscope-associated infections
Endoscope-associated infections due to contaminated endoscopes continue to be reported worldwide. Although endoscope-associated infections are, duodenoscope-related, recent reports also discuss outbreaks related to gastroscopes, colonoscopes, and bronchoscopes. Despite adequate measures to conduct the reprocessing of endoscopes, cases of infections caused due to the use of endoscopes have been significantly high.
Recent studies have assessed duodenoscope contamination incidence rates ranging from 0.3% to 30%, although linear echoendoscopes with a similar complex design, gastroscope, and colonoscopes can also be contaminated. Klebsiella pneumoniae and Pseudomonas aeruginosa are frequently involved in endoscopy-related outbreaks, probably due to their persistence in biofilms. Subject to heavy wear and tear, damaged parts such as biopsy channels are vulnerable to biofilm formation.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=219094994
Emerging economies in the APAC region present lucrative investment opportunities for multinational infection control companies to offshore their business operations to these markets. For instance, in September 2018, Ecolab inaugurated the Greater China Healthcare Innovation and Customer Experience Center in Shanghai. In October 2017, the company expanded its presence across the APAC region by establishing new headquarters in Singapore. Expansions in emerging markets are driving the uptake of endoscope reprocessing products in the medical device manufacturing industry in these countries, thereby providing growth opportunities for the product manufacturers and service providers.
The study involved four major activities to estimate the current size of the endoscope reprocessing market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Market Size Estimation:
Both top-down and bottom-up approaches were used to estimate and validate the total size of the endoscope reprocessing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and markets have been identified through extensive secondary research.
- The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
High-level disinfectants and test strips are expected to hold the largest share of the endoscope reprocessing market, by product in 2021.
Based on product, the global endoscope reprocessing market is segmented into high-level disinfectants and test strips; detergents & wipes; endoscope tracking systems; endoscope drying, storage, and transport systems; automated endoscope reprocessors (AERs); and other products (brushes and flushing aids, leak testers, hookups, and sponges). In 2020, the high-level disinfectants and test strips segment accounted for the largest share of the global endoscope reprocessing market. The large share of this segment can be attributed to the increasing outbreaks linked to inadequate cleaning or disinfecting during HLD, the effectiveness of high-level disinfectants for quality assurance in decontaminating endoscopes, and rising adherence to endoscope reprocessing guidelines by healthcare centers.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=219094994
North America commanded the largest share of the endoscope reprocessing market in 2021.
Based on region, the endoscope reprocessing market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2020, North America commanded the largest share of the endoscope reprocessing market. The largest share of North America can be attributed to factors such as the rising incidence of cancer, favorable reimbursement scenarios, and increasing incidence of endoscope-related infections.
The major players operating in this market are Cantel Medical (US), Advanced Sterilization Products (ASP) (US), Olympus Corporation (Japan), Ecolab (US), STERIS (Ireland), Getinge AB (Sweden), Wassenburg Medical (Netherlands), CONMED Corporation (US), Belimed AG (Switzerland), Endo-Technik W. Griesat (Germany), Custom Ultrasonics (US), Steelco S.p.A. (Italy), BES Healthcare Ltd (UK), ARC Healthcare Solutions (Canada), Metrex Research, LLC. (Canada), Richard Wolf GmbH (Germany), MEDALKAN (Greece), Micro-Scientific, LLC (US), Borer Chemie AG (Switzerland), Tuttnauer (Netherlands), ATMS (Canada), Summit Imaging, Inc. (US), Medonica Co. LTD (South Korea), SHINVA MEDICAL INSTRUMENT CO. LTD (China), and Medical Devices Group Srl (Italy).
Media Contact
Company Name: MarketsandMarkets
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/endoscope-reprocessing-market-219094994.html